Trade now with Barclays Stockbrokers
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -181.2% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 7.0 | n/a |
| Pr/Book | 1.9 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 28.3% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-22 | 4.04 | (2.64) | (3.24)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-23 | 1.75 | (8.30) | (11.35)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-24 | 0.86 | (3.14) | 0.71p | 0.9 | n/a | n/a | n/a | 0.0% |
| 30-Jun-25 | 1.20 | (2.57) | (0.14)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-26 | 1.54 | (2.79) | (0.07)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Voluntary Price Condition on Directors' Options | 12-Nov-2026 | 13:21 | RNS |
| Optimer partnership target heart & skeletal muscle | 26-Oct-2026 | 07:00 | RNS |
| Full Year Results for the 12mths to 30 June 2026 | 13-Oct-2026 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.36p |
| Change Today | 0.083p |
| % Change | 30.30 % |
| 52 Week High | 1.08 |
| 52 Week Low | 0.26 |
| Volume | 27,670,694 |
| Shares Issued | 3,468.08m |
| Market Cap | £12.43m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:48 | 7,500 @ 0.39p |
| 15:42 | 750,000 @ 0.40p |
| 15:42 | 50,000 @ 0.38p |
| 15:39 | 492,435 @ 0.39p |
| 15:36 | 800,000 @ 0.38p |
| CEO | Arron Tolley |
| CFO | Andrew Rapson |
You are here: research